SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E6A680FCB6C43EBC5536D67FCB1A068C8148681AEEFA7C232282116B423B875D3C2CFFD56FA57E78B97F256DA3D8722D>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E6A680FCB6C43EBC5536D67FCB1A068C8148681AEEFA7C232282116B423B875D3C2CFFD56FA57E78B97F256DA3D8722D
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E6A680FCB6C43EBC5536D67FCB1A068C8148681AEEFA7C232282116B423B875D3C2CFFD56FA57E78B97F256DA3D8722D
http://www.w3.org/2000/01/rdf-schema#comment
"Results confirm the importance of the CYP2C9*3 variant in conferring a multiple drug-resistant phenotype against antiepileptic drugs."
xsd:string
http://purl.uniprot.org/uniprot/#_47BDF899C70557F8339AE8DE9897AF7B8C527464D96DB2D07D1B190673E0CD883FBAE750AC08529DD10ED4096B166F55
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E6A680FCB6C43EBC5536D67FCB1A068C8148681AEEFA7C232282116B423B875D3C2CFFD56FA57E78B97F256DA3D8722D
http://purl.uniprot.org/uniprot/A0A0A7MA87
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E6A680FCB6C43EBC5536D67FCB1A068C8148681AEEFA7C232282116B423B875D3C2CFFD56FA57E78B97F256DA3D8722D
http://purl.uniprot.org/uniprot/#_A0A0A7MA87-mappedCitation-24338437
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E6A680FCB6C43EBC5536D67FCB1A068C8148681AEEFA7C232282116B423B875D3C2CFFD56FA57E78B97F256DA3D8722D